Results     09-May-24
Announcements
Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
Sales rise 7.86% to Rs 1516.98 crore
Net profit of Alembic Pharmaceuticals rose 16.78% to Rs 178.21 crore in the quarter ended March 2024 as against Rs 152.60 crore during the previous quarter ended March 2023. Sales rose 7.86% to Rs 1516.98 crore in the quarter ended March 2024 as against Rs 1406.45 crore during the previous quarter ended March 2023.

For the full year,net profit rose 80.07% to Rs 615.82 crore in the year ended March 2024 as against Rs 341.99 crore during the previous year ended March 2023. Sales rose 10.19% to Rs 6228.63 crore in the year ended March 2024 as against Rs 5652.62 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1516.981406.45 8 6228.635652.62 10
OPM %17.1214.49 -14.9711.98 -
PBDT252.33190.29 33 904.50630.02 44
PBT182.85116.17 57 631.83354.59 78
NP178.21152.60 17 615.82341.99 80

Previous News
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 08-Jun-23   14:30 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 20-Jul-23   14:30 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Volumes spurt at One 97 Communications Ltd counter
 ( Hot Pursuit - 08-Jun-23   11:00 )
  Intellect Design Arena Ltd leads losers in 'A' group
 ( Hot Pursuit - 10-May-24   15:00 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals receives USFDA approval for Glycopyrrolate Injection
 ( Corporate News - 01-Nov-22   11:41 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top